United States · FDA National Drug Code directory
lamotrigine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-095_8b09deb8-500f-428a-b588-6a238c7c553c
- Product NDC
- 62332-095
- Form
- TABLET, FOR SUSPENSION
- Composition / generic term
- lamotrigine
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140411
- Source listing expiry
- 20271231
Source-listed ingredients
- LAMOTRIGINE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-095-30) · 62332-095-30
- 100 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-095-31) · 62332-095-31
- 1000 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-095-91) · 62332-095-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →